DMVeille DM

Field safety notices: Omixon Biocomputing Ltd.

Manufacturer registered in EUDAMED: SRN HU-MF-000003018 ; country: Hungary

5 authority publications by one authority, from 16 Oct 2019 to 13 Aug 2024.

Latest notice: 13 Aug 2024, ANSM, Réactifs Holotype HLA products

Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Omixon Biocomputing Ltd. or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.

4 distinct corrective actions.

  1. Réactifs Holotype HLA products

    Source : ANSM, informations de sécurité · collected 16 Nov 2026

  1. Logiciel Omixon HLA Twin CE

    Source : ANSM, informations de sécurité · collected 16 Nov 2026

Corrective action: 2 publications by ANSM, from 19 Feb 2020 to 10 Mar 2020

  1. Logiciel Omixon HLA TWIN CE

    Source : ANSM, informations de sécurité · collected 16 Nov 2026

  2. Réactifs Holotype HLA 96/7 – Différentes configurations

    Source : ANSM, informations de sécurité · collected 16 Nov 2026

  1. Configuration A & CE, Holotype HLA 96/7 – Configuration A & CE v2, Holotype HLA 96/7 Configuration B et CE v2

    Source : ANSM, informations de sécurité · collected 16 Nov 2026

The authorities that published these notices